Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
TiVo Inc. ( TIVO - Analyst Report ) and Microsoft Corp. ( MSFT - Analyst Report ) have settled their ongoing patent litigation disputes by dropping all charges against each other. Since 2010, both the companies remained entangled in legal disputes that involved suits and counter suits relating to a certain DVR technology patent. However, Bloomberg reported that no monetary transaction was discussed in the settlement, and TiVo did not grant any patent rights to Microsoft.
In 2009, TiVo had sued AT&T Inc. ( T - Analyst Report ) , a Microsoft client, for infringing upon three of its DVR patents. Thereafter, to lend support to its client, Microsoft sued TiVo in 2010. However, in January 2012, AT&T settled its dispute with TiVo for $215.0 million and both the companies dropped all pending litigation charges against each other.
As TiVo and Microsoft settle their litigation cases, it remains to be seen whether Verizon Communications Inc. ( VZ - Analyst Report ) will tread the same path.
TiVo has been defending its patents that have yielded a recurring revenue stream. TiVo’s successful intellectual property monetization began with the $500 million time warp patent settlement with DISH Network and EchoStar Corporation ( SATS ) . The recent settlement with AT&T ensured an upfront payment of $51 million and the remaining $164 million on a quarterly basis through 2018.
Moreover, the present settlement will also bring down the litigation expenses that TiVo incurs every quarter. In the recently concluded quarter, TiVo incurred $16 million in legal settlement expenses and gained $54.4 million from litigation proceeds. Moreover, management expects litigation expenses in the current quarter to decrease significantly with less legal disputes.
We remain optimistic about TiVo’s long-term growth potential due to new partnerships, product launches and international expansion. We believe that TiVo will continue to witness strong subscriber growth based on its partnerships with Virgin Media Inc. ( VMED - Analyst Report ) , RCN, ONO, Charter Communications, Suddenlink and DIRECTV going forward.
However, pending patent litigation issues, rising subscription acquisition costs and higher R&D expenses are expected to impact TiVo’s profitability over the next few quarters. Increasing competition from cable and satellite providers could also hurt profitability over the long term. Thus, we have a long-term Neutral recommendation on TiVo.
Currently, TiVo has a Zacks #3 Rank, which implies a ‘Hold’ rating in the short term.
Read the full reports :
Analyst Report on T
Analyst Report on MSFT
Analyst Report on VMED
Analyst Report on VZ
Analyst Report on TIVO
on SATS